Key Takeaways Federal regulators have issued a warning about rare heart inflammation in young males after mRNA COVID ...

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...

Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.